There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 25+ companies and 30+ ...

The Competition Commission played a pivotal role in South Africa's historic fight for access to HIV medicines.

There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving cancer medicines seem set to nail down what qualifies as "excessive ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for cancer based on its unique Mimicry platform, will be holding a webinar to run through new clinical data from the ...

Intrinsic Tumor Drivers and Immune Escape Mechanisms in CD19 CAR T-Cell Therapy Resistance for Aggressive Large ...

And notably, response to imetelstat were seen in patients receiving prior treatments, including luspatercept, lenalidomide, and HMA. The third, IMerge Abstract 3210, accepted as a poster ...